Company Profile

Monterey Innovation Acquisition Corp., formerly Monterey Bio Acquisition Corp., is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The Company intends to focus its efforts on identifying a disruptive technology company.

Employees

Sector

Investment Holding Companies

More about the company

23-11-20	Monterey Innovation Acquisition Corp.(NasdaqGM:MTRY) dropped from NASDAQ Composite Index	CI
23-08-22	Monterey Innovation Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-05-18	Monterey Innovation Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-04-17	Monterey Bio Acquisition Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-04-16	Monterey Innovation Acquisition Corp. Auditor Raises 'Going Concern' Doubt	CI
23-03-10	Monterey Bio Acquisition to Change Name to Monterey Innovation Acquisition	MT
23-03-10	Monterey Bio Acquisition Corporation Announces Board Changes	CI
23-03-10	Monterey Bio Acquisition Corporation Appoints Murat Omur as Chief Executive Officer	CI
23-03-10	Monterey Bio Acquisition Corporation Appoints Sean McGann as Chief Financial Officer	CI
22-11-10	Monterey Bio Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
22-10-06	Monterey Innovation Acquisition Corp. announced that it expects to receive $0.7 million in funding from Northstar Bio Ventures, LLC, Chardan Monterey Investments LLC	CI
22-08-11	Monterey Bio Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
22-05-13	Monterey Bio Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	CI

23-04-17	MONTEREY INNOVATION ACQUISITION CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
23-03-10	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
22-11-10	MONTEREY BIO ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
22-10-11	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	AQ
22-09-30	MONTEREY BIO ACQUISITION CORP : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ

Manager	Title	Age	Since
Murat Omur CEO	Chief Executive Officer	48	2023-03-08
Sanjeev Satyal CEO	Chief Executive Officer	57	2021-03-31
David Smith PRN	Corporate Officer/Principal	66	-

Director	Title	Age	Since
James Neal CHM	Chairman	70	2021-09-29
Frances K. Heller BRD	Director/Board Member	59	2021-09-29
Jonas Grossman CHM	Chairman	52	2023-03-08

Date	Insider	Type	Main position	Quantity	% Market Cap.
23-03-08	Sandip I. Patel	Sell	Director	645,000	13.1784%
23-03-08	Jonas Grossman	Sell	Chairman	491,250	10.0370%
23-03-08	Sanjeev Satyal	Others	Executive/Senior Manager	75,000	1.5324%

Monterey Innovation Acquisition Corp. Stock

Stocks

MTRY

US61240F1084

Investment Holding Companies

Latest news : Monterey Innovation Acquisition Corp.

Press Releases: Monterey Innovation Acquisition Corp.

Quotes and Performance

Managers and Directors: Monterey Innovation Acquisition Corp.

Latest insider transactions

Shell Companies

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MONTEREY INNOVATION ACQUISITION CORP.	-0.09%	-1.59%	-	-	48.3M
EINRIDE AB	-15.54%	-29.74%	-	-	1.18B
CENTIEL AG	+3.65%	+11.23%	+439.24%	-57.19%	831M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	-0.10%	+0.10%	-	-	643M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.59%	+0.59%	-	-	596M
CANTOR EQUITY PARTNERS IV, INC.	-0.39%	+0.10%	-	-	593M
CHURCHILL CAPITAL CORP XI	+0.63%	+1.27%	-	-	574M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	+0.18%	-0.89%	-	-	551M
ENHANCED GROUP INC.	+11.03%	+18.13%	-	-	541M
Average	-0.00%	-0.43%	+439.24%	-57.19%	688.61M
Weighted average by Cap.	-1.58%	-3.18%	+439.24%	-57.19%